In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology

Journal of Clinical Investigation

Volumn 122, Issue 1, 2012, Pages 408-418

  Tsai, Michelle ^a,b,c   Kita, Ashley ^a,b,c   Leach, Joseph ^d   Rounsevell, Ross ^a   Huang, James N ^e   Moake, Joel ^f   Ware, Russell E ^g   Fletcher, Daniel A ^a,h   Lam, Wilbur A ^b,c,i,j  

^a University of California at Berkeley   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Rice University   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^j EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPTIFIBATIDE; HYDROXYUREA;

ARTERIOLE; ARTICLE; BIOASSAY; BIOLOGICAL MODEL; BLOOD FLOW; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CAPILLARY; CONTROLLED STUDY; DRUG EFFICACY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROCHIP ANALYSIS; MICROFLUIDICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHEAR STRESS; SICKLE CELL ANEMIA; THROMBOCYTE AGGREGATION; THROMBOSIS; VENULE;

ANEMIA, SICKLE CELL; HEMATOLOGIC DISEASES; HEMOLYTIC-UREMIC SYNDROME; HEMORHEOLOGY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROXYUREA; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROSCOPY, FLUORESCENCE; MICROVESSELS; MODELS, CARDIOVASCULAR; PEPTIDES; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 84855468373     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58753     Document Type: Article

References (57)

1. Ballas SK, Mohandas N. Sickle red cell microrheology and sickle blood rheology. Microcirculation. 2004;11(2):209-225. (Pubitemid 39619080)
2. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337(11):762-769. (Pubitemid 27417977)
3. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589-600.
4. Lipowsky HH. Microvascular rheology and hemodynamics. Microcirculation. 2005;12(1):5-15. (Pubitemid 40450614)
5. Barabino GA, Platt MO, Kaul DK. Sickle cell biomechanics. Annu Rev Biomed Eng. 2010;12:345-367.
6. Bao G, Suresh S. Cell and molecular mechanics of biological materials. Nat Mater. 2003;2(11):715-725.
7. Kaul DK, Finnegan E, Barabino GA. Sickle red cell-endothelium interactions. Microcirculation. 2009;16(1):97-111.
8. Mezzano D, Quiroga T, Pereira J. The level of laboratory testing required for diagnosis or exclusion of a platelet function disorder using platelet aggregation and secretion assays. Semin Thromb Hemost. 2009;35(2):242-254.
9. Young EW, Beebe DJ. Fundamentals of microfluidic cell culture in controlled microenvironments. Chem Soc Rev. 2010;39(3):1036-1048.
10. Young EW, Simmons CA. Macro- and microscale fluid flow systems for endothelial cell biology. Lab Chip. 2010;10(2):143-160.
11. Higgins JM, Eddington DT, Bhatia SN, Mahadevan L. Sickle cell vasoocclusion and rescue in a microfluidic device. Proc Natl Acad Sci U S A. 2007;104(51):20496-20500.
12. Rosano JM, et al. A physiologically realistic in vitro model of microvascular networks. Biomed Microdevices. 2009;11(5):1051-1057.
13. Kotz KT, et al. Clinical microfluidics for neutrophil genomics and proteomics. Nat Med. 2010;16(9):1042-1047.
14. Rosenbluth MJ, Lam WA, Fletcher DA. Analyzing cell mechanics in hematologic diseases with microfluidic biophysical flow cytometry. Lab Chip. 2008;8(7):1062-1070. (Pubitemid 351904828)
15. Shelby JP, White J, Ganesan K, Rathod PK, Chiu DT. A microfluidic model for single-cell capillary obstruction by Plasmodium falciparuminfected erythrocytes. Proc Natl Acad Sci U S A. 2003;100(25):14618-14622. (Pubitemid 37517939)
16. Borenstein JT, et al. Functional endothelialized microvascular networks with circular cross-sections in a tissue culture substrate. Biomed Microdevices. 2010;12(1):71-79.
17. Nesbitt WS, et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med. 2009;15(6):665-673.
18. Fiddes LK, et al. A circular cross-section PDMS microfluidics system for replication of cardiovascular flow conditions. Biomaterials. 2010;31(13):3459-3464.
19. Lee SH, Kang do H, Kim HN, Suh KY. Use of directly molded poly(methyl methacrylate) channels for microf luidic applications. Lab Chip. 2010;10(23):3300-3306.
20. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflugers Arch. 2010;459(6):807-816.
21. Qiu W, Kass DA, Hu Q, Ziegelstein RC. Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5- diaminofluorescein fluorescence. Biochem Biophys Res Commun. 2001;286(2):328-335. (Pubitemid 32924917)
22. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol. 2008;28(2):223-232. (Pubitemid 351161193)
23. Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF, Gaehtgens P. Resistance to blood flow in microvessels in vivo. Circ Res. 1994;75(5):904-915. (Pubitemid 24323525)
24. Fung YC. Biomechanics: Circulation. 2nd ed. New York, New York, USA: Springer Publishing; 1997.
25. Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res. 2007; 100(12):1673-1685. (Pubitemid 46987859)
26. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55(5):662-675. (Pubitemid 24171735)
27. Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest. 1991;87(5):1798-1804.
28. Ishikawa M, et al. Platelet adhesion and arteriolar dilation in the photothrombosis: observation with the rat closed cranial and spinal windows. J Neurol Sci. 2002;194(1):59-69. (Pubitemid 34051557)
29. Dirnagl U, Niwa K, Sixt G, Villringer A. Cortical hypoperfusion after global forebrain ischemia in rats is not caused by microvascular leukocyte plugging. Stroke. 1994;25(5):1028-1038. (Pubitemid 24130312)
30. Sluiter W, Pietersma A, Lamers JM, Koster JF. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol. 1993;22(suppl 4):S37-S44. (Pubitemid 23329999)
31. Pathare A, Kindi SA, Daar S, Dennison D. Cytokines in sickle cell disease. Hematology. 2003;8(5):329-337. (Pubitemid 37322190)
32. Lucas R, Lou J, Morel DR, Ricou B, Suter PM, Grau GE. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol. 1997;61(5):551-558. (Pubitemid 27234451)
33. Worthen GS, Schwab B 3rd, Elson EL, Downey GP. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science. 1989;245(4914):183-186. (Pubitemid 19193935)
34. Nash GB, Johnson CS, Meiselman HJ. Rheologic impairment of sickle RBCs induced by repetitive cycles of deoxygenation-reoxygenation. Blood. 1988;72(2):539-545.
35. Mohandas N, Evans E. Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins. J Clin Invest. 1985;76(4):1605-1612. (Pubitemid 16193582)
36. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M. Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood. 1987;70(1):152-157. (Pubitemid 17111255)
37. Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010; 115(26):5300-5311.
38. Athanassiou G, Moutzouri A, Kourakli A, Zoumbos N. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia. Clin Hemorheol Microcirc. 2006;35(1-2):291-295. (Pubitemid 44126517)
39. Brandao MM, et al. Optical tweezers for measuring red blood cell elasticity: application to the study of drug response in sickle cell disease. Eur J Haematol. 2003;70(4):207-211. (Pubitemid 36469756)
40. Bridges KR, et al. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood. 1996;88(12):4701-4710. (Pubitemid 26419155)
41. Ware RE, Aygun B. Advances in the use of hydroxyurea. Hematology Am Soc Hematol Educ Program. 2009:62-69.
42. Gladwin MT, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol. 2002;116(2):436-444. (Pubitemid 34155519)
43. Ware RE, et al. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood. 2002;99(1):10-14. (Pubitemid 34532957)
44. Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114(25):5117-5125.
45. Cheung AT, et al. Microvascular abnormalities in sickle cell disease: a computer-assisted intravital microscopy study. Blood. 2002;99(11):3999-4005. (Pubitemid 35332040)
46. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384-391.
47. Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol. 2010;25(11):2231-2240.
48. Nolasco LH, et al. Hemolytic uremic syndromeassociated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood. 2005;106(13):4199-4209. (Pubitemid 41775927)
49. Morigi M, et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood. 2001;98(6):1828-1835.
50. Chau L, Doran M, Cooper-White J. A novel multishear microdevice for studying cell mechanics. Lab Chip. 2009;9(13):1897-1902.
51. Green DA, Murphy WG, Uttley WS. Haemolytic uraemic syndrome: prognostic factors. Clin Lab Haematol. 2000;22(1):11-14. (Pubitemid 30196538)
52. Walters MD, Matthei IU, Kay R, Dillon MJ, Barratt TM. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol. 1989;3(2):130-134. (Pubitemid 19100370)
53. Curran MP, Keating GM. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs. 2005;65(14):2009-2035. (Pubitemid 41327369)
54. Mathur AB, Reichert WM, Truskey GA. Flow and high affinity binding affect the elastic modulus of the nucleus, cell body and the stress fibers of endothelial cells. Ann Biomed Eng. 2007;35(7):1120-1130. (Pubitemid 46966262)
55. Armani D, Liu C, Aluru N. Re-configurable fluid circuits by PDMS elastomer micromachining. Presented at: Micro Electro Mechanical Systems, 1999. MEMS '99. Twelfth IEEE International Conference; January 17-21, 1999; Orlando, Florida, USA.
56. Reinke W, Gaehtgens P, Johnson PC. Blood viscosity in small tubes: effect of shear rate, aggregation, and sedimentation. Am J Physiol. 1987; 253(3 pt 2):H540-H547.
57. Dangaria JH, Butler PJ. Macrorheology and adaptive microrheology of endothelial cells subjected to fluid shear stress. Am J Physiol Cell Physiol. 2007;293(5):C1568-C1575. (Pubitemid 350085636)